Researchers have identified a mechanism that could help explain how ketamine helps relieve symptoms of depression.
A new study reports nitrous oxide is showing promise as an effective treatment for depression.
Chronic stress can affect a person's health and mental well being. Due to the COVID-19 virus, chronic stress is on the rise worldwide. Researchers examine the general and psychological health implications of chronic stress and suggest some methods we can adopt to keep our stress levels in check.
People with untreated depression have lower levels of mitochondrial proteins. For those who responded to the SSRI antidepressants, the proteins returned to a normal level, but showed no increase in those who did not respond to medication.
Retinal ganglion cell survival following a stroke depends on whether the pathway to the primary visual area remains active. Cells connected to inactive areas of the visual cortex suffer atrophy and degenerate, leading to permanent visual impairment.
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.
Differences in serotonergic neuron morphology, along with altered gene expression have been identified in patients with MDD. The findings shed light on why some patients do not respond to SSRI antidepressants.
A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.
Fluoxetine rearranges nerve fibers in the hippocampus of mice, a new study reports.
Researchers discover a gene which may reveal how well a person is likely to respond to SSRI antidepressants.
Fetal exposure to SRI antidepressants may affect the brain activity in newborns, a new study reports.
A new study in mice reveals a possible link between the use of SSRI antidepressants during pregnancy and an increased risk of autism-like symptoms in offspring. Offspring exposed to fluoxetine (Prozac) in utero were more likely to exhibit impaired neurotransmission caused by an overactive serotonin receptor in the prefrontal cortex, an area of the brain implicated in modulating social behaviors. However, treating the mice with a compound that blocks the receptor alleviated the behavioral problems and improved working memory.
